4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-048789
Chairman and CEO bought 32,499 shares at an average $4.03 ($130,918)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-09-04 | Purchase | +20,000 | $3.99 | $79,800 | 50,501 | I |
| Niihara Yutaka Chairman and CEO | 2019-09-05 | Purchase | +9,672 | $4.04 | $39,075 | 60,173 | I |
| Niihara Yutaka Chairman and CEO | 2019-09-06 | Purchase | +2,827 | $4.26 | $12,043 | 63,000 | I |
| Open-market purchases · 32,499 sh · avg $4.03 · $130,918 | |||||||
Loading xslF345X03/doc4.xml…